SEP 11, 2026 · INTERVENTIONAL STUDY
Molecular Signatures of TMS Response in Treatment-Resistant Depression
ClinicalTrials.gov
This is an active, unblinded, single-arm biomarker discovery study with no results yet reported; it aims to identify proteomic and metabolomic signatures of TMS response but has not yet yielded outcome data.
Reported
Planned enrollment55
Primary outcome measure 1Plasma Proteomic Profile Changes After TMS…
Primary outcome measure 2Plasma Metabolomic Profile Changes After TM…